Senores Pharmaceuticals Ltd

NSE: SENORES · BSE: 544319 · Pharmaceuticals & Biotechnology · 40 announcements

Share price: ₹1,391.10
Market cap: ₹6,407 Cr
Revenue (annual): ₹632.6 Cr
Net profit (annual): ₹115.4 Cr
P/E (TTM): 50.7×Sector 47.4×
Promoter holding: 45.82%+0.00% QoQ
FII holding: 6.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

29 Jun 2026 19:44 IST BSE

Fund RaiseAlfa Alert

Senores Pharmaceuticals Fund Raise of ₹100 Cr

Senores Pharmaceuticals approved revised utilisation of ₹100 Crore from unutilised IPO proceeds. The change is subject to shareholder approval via postal ballot.

Value: ₹100.0 Cr

Read the filing ↗

14 May 2026 15:25 IST NSE

Fund Raise

Senores Pharmaceuticals Fund Raise of ₹500 Cr

Senores Pharmaceuticals Limited submitted its Monitoring Agency Report for the Rs.500 Crore IPO proceeds. The filing confirms fund deployment for objects including debt repayment and growth.

Value: ₹500.0 Cr

Read the filing ↗